Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) disease, today ...

A German tourist was allegedly extorted by a fake police officer for protection against thugs in Pattaya. Udo Helmut Dei ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Predictive Oncology (POAI) announced that it has made significant progress along the continuum of biomarker discovery, drug discovery and drug ...

New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell tumors ...

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

MilliporeSigma's Curiosity Labs™ program now features a new lesson on the role of artificial intelligence in drug discovery. ...

LinkedIn, the world’s largest professional network, today unveiled the 2025 Top Midsize Companies India list, featuring 15 ...